Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.290
-0.030 (-2.27%)
At close: Feb 21, 2025, 4:00 PM
1.260
-0.030 (-2.33%)
After-hours: Feb 21, 2025, 5:14 PM EST
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $54.84 million as of February 21, 2025. Its market cap has decreased by -83.71% in one year.
Market Cap
54.84M
Enterprise Value
-122.03M
1-Year Change
-83.71%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $54.84M, a decrease of -94.20%. That is a compound annual growth rate of -45.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 54.84M | -1.53% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |